<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3B1E5961-8677-4A32-B15C-12FB968FA163"><gtr:id>3B1E5961-8677-4A32-B15C-12FB968FA163</gtr:id><gtr:name>University of Pennsylvania</gtr:name><gtr:address><gtr:line1>3451 Walnut Street,</gtr:line1><gtr:line2>Suite P-221</gtr:line2><gtr:line3>Franklin Building</gtr:line3><gtr:line4>Philadelphia</gtr:line4><gtr:postCode>PA 19104</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Cambridge Institute for Medical Research</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3B1E5961-8677-4A32-B15C-12FB968FA163"><gtr:id>3B1E5961-8677-4A32-B15C-12FB968FA163</gtr:id><gtr:name>University of Pennsylvania</gtr:name><gtr:address><gtr:line1>3451 Walnut Street,</gtr:line1><gtr:line2>Suite P-221</gtr:line2><gtr:line3>Franklin Building</gtr:line3><gtr:line4>Philadelphia</gtr:line4><gtr:postCode>PA 19104</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/29E28B0A-0B19-4075-B4EE-C67C6844C753"><gtr:id>29E28B0A-0B19-4075-B4EE-C67C6844C753</gtr:id><gtr:firstName>James</gtr:firstName><gtr:otherNames>Andrew</gtr:otherNames><gtr:surname>Huntington</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0601596"><gtr:id>C8C1B7B7-D7E4-431C-9ADA-179C0A6BA24E</gtr:id><gtr:title>Structural Basis of Molecular Recognition in Haemostasis</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0601596</gtr:grantReference><gtr:abstractText>Blood coagulation is a complex process under tight regulatory control. In response to blood vessel rupture, a cascade of events leads to the rapid and localised deposition of a blood clot which staunches the flow of blood from the wound. Bleeding results if the clotting response is insufficiently rapid and robust, however, if coagulation is not limited, the clot will over-grow resulting in thrombosis. This ?haemostatic balance? is critical for human health, and understanding the regulatory mechanisms is crucial for the diagnosis, prevention and treatment of thrombosis, the leading cause of morbidity and mortality in the industrialised world. The goal of this study is to understand the factors which tip blood clotting from its precarious balance to cause diseases such as haemophilia, deep vein thrombosis, pulmonary embolism, heart attack, and stroke. This will be achieved by obtaining molecular pictures of the multi-protein complexes which are formed at critical stages of blood coagulation, primarily by using the technique of X-ray crystallography. Such detailed pictures will help determine why certain people are more susceptible to coagulation disorders, and will underpin the development of novel therapies to prevent and treat thrombosis.</gtr:abstractText><gtr:technicalSummary>Haemostasis is a complex process under tight regulatory control. In response to blood vessel rupture, a cascade of events leads to the rapid and localised deposition of a fibrin plug (clot) which staunches the loss of blood. Haemorrhage results if this response is insufficiently robust, however, thrombosis occurs if it is not attenuated. The balance between the procoagulant and anticoagulant forces is therefore critical for human health, and understanding the regulatory mechanisms is crucial for the diagnosis, prevention and treatment of thrombosis, the leading cause of morbidity and mortality in the industrialised world. To understand the regulation of haemostasis, how dysregulation causes disease, and to develop strategies for specific therapeutic interventions, it is necessary to determine the structural basis of the macromolecular interactions which govern the haemostatic balance. This will significantly be achieved through successful completion of the aims outlined in this proposal. In aims 1 and 2 we determine how the two major inhibitors of the coagulation proteases, antithrombin and heparin cofactor II, are stimulated by the drug heparin to prevent thrombosis. The mechanisms of stimulation of protein C inhibitor by heparin, thrombomodulin and phospholipids are the focus of aim 3. Protein C inhibitor is a circulating serpin, like antithrombin and heparin cofactor II, but it functions as a procoagulant by inhibiting the proteases of the anticoagulant protein C system. Thus, aims 1-3 focus on how the haemostatic serpins are regulated by cofactors. The final protease generated during the blood coagulation cascade, thrombin, is the subject of aim 4. Thrombin is the only protease capable of cleaving fibrinogen and is the most potent stimulator of platelets, but it also serves a critical anticoagulant role by activating protein C. Understanding how thrombin substrate selectivity is conferred is central to understanding the haemostatic balance. This will be achieved through a two-pronged approach of crystallography and NMR studies. The final aim, aim 5, is to determine the crystallographic structure of the enzyme complex which forms thrombin from its zymogen. The ?prothrombinase? complex (factor Va, factor Xa and phospholipids) generates thrombin 300,000-times more rapidly than factor Xa alone. How this complex is formed and how it specifically recognises prothrombin are critical determinants of the haemostatic response. All aims utilise X-ray crystallography as the principal method, but solution techniques, such as spectroscopy, enzyme kinetics and NMR, will also be used.</gtr:technicalSummary><gtr:fund><gtr:end>2011-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-07-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1242404</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Biochemistry</gtr:department><gtr:description>NMR</gtr:description><gtr:id>3642F331-8FD1-4C40-8A68-7D118E61072C</gtr:id><gtr:impact>We assigned resonance assignments for thrombin in several states, resulting in two publications:
Lechtenberg BC, Freund SMV, Huntington JA, 2014, GpIba interacts exclusively with exosite II of thrombin, J Mol Biol. 426(4):881-93.
Lechtenberg, BC, Johnson, DJD, Freund, S and Huntington, JA, 2010, NMR resonance assignments of thrombin reveal the conformational and dynamic effects of ligation, Proc. Natl. Acad. Sci. USA, 107(32):14087-92.</gtr:impact><gtr:outcomeId>b8sZyn8GNWd-1</gtr:outcomeId><gtr:partnerContribution>They set up and interpret the NMR experiments.</gtr:partnerContribution><gtr:piContribution>We conceive the projects, design the studies, produce the NMR samples, generate resonance assignments, interpret results and write manuscripts.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Laboratory of Molecular Biology (LMB)</gtr:department><gtr:description>NMR</gtr:description><gtr:id>1297A3A8-747E-4691-BEF8-60DBDB832F48</gtr:id><gtr:impact>We assigned resonance assignments for thrombin in several states, resulting in two publications:
Lechtenberg BC, Freund SMV, Huntington JA, 2014, GpIba interacts exclusively with exosite II of thrombin, J Mol Biol. 426(4):881-93.
Lechtenberg, BC, Johnson, DJD, Freund, S and Huntington, JA, 2010, NMR resonance assignments of thrombin reveal the conformational and dynamic effects of ligation, Proc. Natl. Acad. Sci. USA, 107(32):14087-92.</gtr:impact><gtr:outcomeId>b8sZyn8GNWd-2</gtr:outcomeId><gtr:partnerContribution>They set up and interpret the NMR experiments.</gtr:partnerContribution><gtr:piContribution>We conceive the projects, design the studies, produce the NMR samples, generate resonance assignments, interpret results and write manuscripts.</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Pennsylvania</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Pediatrics</gtr:department><gtr:description>Thrombin ITC</gtr:description><gtr:id>FE853069-58BA-4082-B87B-4468EAD7CEC3</gtr:id><gtr:impact>We have published a paper together.</gtr:impact><gtr:outcomeId>QEZh4fneSSa-1</gtr:outcomeId><gtr:partnerContribution>The provided protein and use techniques not available here.</gtr:partnerContribution><gtr:piContribution>Help in developing ideas. Provided a mutant. Helped analyse data and write paper.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>420000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Equpment Grant (Crystallisation robotics in the Cambridge Institute for Medical Research)</gtr:description><gtr:end>2013-05-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>9A6C10C9-2F69-402C-AB19-9D05AB45801A</gtr:id><gtr:outcomeId>bUNHydfbony0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>315875</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2012-04-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>D129D863-C757-42EA-9FC1-7EE1BF5497A1</gtr:id><gtr:outcomeId>BCMer5gMj4w0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>164000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>project grant</gtr:description><gtr:end>2014-07-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>B4F07EDC-22D5-4C8A-8091-F112AECD77B8</gtr:id><gtr:outcomeId>XLVcE1pqHR50</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>101583</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF PhD Studentship</gtr:description><gtr:end>2012-12-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>67FA4506-DEDE-400C-A44E-2BBC158ED781</gtr:id><gtr:outcomeId>8398AE967770</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-12-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>An antithrombotic antibody.</gtr:description><gtr:grantRef>G0601596</gtr:grantRef><gtr:id>7F0242ED-DEAC-442A-90EA-076FD35FB846</gtr:id><gtr:impact>NA</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>eF5tWZ3jLEc</gtr:outcomeId><gtr:patentId>GB1121513.4</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Thrombin-Binding Antibody Molecules and Uses Thereof</gtr:title><gtr:yearProtectionGranted>2011</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs><gtr:spinOutOutput><gtr:companyName>ApcinteX Ltd</gtr:companyName><gtr:description>ApcinteX is a virtual biopharmaceutical company developing SerpinPC as a novel bypassing agent to treat bleeding disorders.</gtr:description><gtr:id>458C4BA8-FD21-4969-939B-04A762BF44D8</gtr:id><gtr:impact>Seed phase funding was obtained to de-risk asset prior to a full Series A round. &amp;pound;14M Series A round completed 7 December 2016.</gtr:impact><gtr:outcomeId>5464b2f053a1b7.36716424</gtr:outcomeId><gtr:yearCompanyFormed>2014</gtr:yearCompanyFormed></gtr:spinOutOutput></gtr:spinOutOutputs></gtr:output><gtr:publications><gtr:publication><gtr:id>3DB03564-B58A-4403-A0C3-640CF6FE99F5</gtr:id><gtr:title>Crystal structure of the prothrombinase complex from the venom of Pseudonaja textilis.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74d6a3ffbc86542d4a9b4f027be05af4"><gtr:id>74d6a3ffbc86542d4a9b4f027be05af4</gtr:id><gtr:otherNames>Lechtenberg BC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>pm_12842_22_23869089</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F89AC34-051D-40A8-82EE-7CA6E5919A36</gtr:id><gtr:title>The heparin binding site of protein C inhibitor is protease-dependent.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ce73e661495882f5061c864c6e2c1985"><gtr:id>ce73e661495882f5061c864c6e2c1985</gtr:id><gtr:otherNames>Li W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>D31B18EDED4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>52E77AE2-15E8-4E20-BC70-28861C0DBA58</gtr:id><gtr:title>Ligand binding shuttles thrombin along a continuum of zymogen- and proteinase-like states.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9e9b9693118fb616c816264129625e78"><gtr:id>9e9b9693118fb616c816264129625e78</gtr:id><gtr:otherNames>Kamath P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>DgxtMoaiji4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C313A32-425D-476D-8531-C3CA81E2C379</gtr:id><gtr:title>Thrombin plasticity.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7823177e5f34aa3434ec7d9a3574641e"><gtr:id>7823177e5f34aa3434ec7d9a3574641e</gtr:id><gtr:otherNames>Huntington JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>JZUXVVWP7j3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C435803-34E6-41FE-9111-1425E3E1B0BF</gtr:id><gtr:title>NMR resonance assignments of thrombin reveal the conformational and dynamic effects of ligation.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74d6a3ffbc86542d4a9b4f027be05af4"><gtr:id>74d6a3ffbc86542d4a9b4f027be05af4</gtr:id><gtr:otherNames>Lechtenberg BC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>AtXrqmdXqUw</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BCE57AD9-1CDC-4CA5-80C7-AA19DA3544FD</gtr:id><gtr:title>Molecular basis of factor IXa recognition by heparin-activated antithrombin revealed by a 1.7-A structure of the ternary complex.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e7c03df186a731bfc5c64a4410e3a0f"><gtr:id>5e7c03df186a731bfc5c64a4410e3a0f</gtr:id><gtr:otherNames>Johnson DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>fw7joVA3URK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D976C02F-4904-4012-B080-D9EAABFE459C</gtr:id><gtr:title>Thrombin inhibition by the serpins.</gtr:title><gtr:parentPublicationTitle>Journal of thrombosis and haemostasis : JTH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7823177e5f34aa3434ec7d9a3574641e"><gtr:id>7823177e5f34aa3434ec7d9a3574641e</gtr:id><gtr:otherNames>Huntington JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1538-7836</gtr:issn><gtr:outcomeId>pm_12842_22_23809129</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>28F9D520-9CEF-4103-BC4B-8D5A3F8D22FC</gtr:id><gtr:title>Crystal structures of protease nexin-1 in complex with heparin and thrombin suggest a 2-step recognition mechanism.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ce73e661495882f5061c864c6e2c1985"><gtr:id>ce73e661495882f5061c864c6e2c1985</gtr:id><gtr:otherNames>Li W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>pm_12842_22_22618708</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4680D5EE-70DE-4FC0-B09B-FF4FD9051286</gtr:id><gtr:title>Phosphatidylethanolamine critically supports internalization of cell-penetrating protein C inhibitor.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3504db6da352fdc78e93e6aeb2e30c29"><gtr:id>3504db6da352fdc78e93e6aeb2e30c29</gtr:id><gtr:otherNames>Baumg?rtner P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn><gtr:outcomeId>DD8AF68B480</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0D73892B-2D5D-4BC5-A527-2E2E2931AFD0</gtr:id><gtr:title>Structural insights into the multiple functions of protein C inhibitor.</gtr:title><gtr:parentPublicationTitle>Cellular and molecular life sciences : CMLS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7823177e5f34aa3434ec7d9a3574641e"><gtr:id>7823177e5f34aa3434ec7d9a3574641e</gtr:id><gtr:otherNames>Huntington JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1420-682X</gtr:issn><gtr:outcomeId>D85C4F9F022</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>970E3EB3-E27F-4C26-BE29-4809F6C59441</gtr:id><gtr:title>Thrombin inhibition by serpins disrupts exosite II.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ce73e661495882f5061c864c6e2c1985"><gtr:id>ce73e661495882f5061c864c6e2c1985</gtr:id><gtr:otherNames>Li W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>S813jjVtvfL</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5EDD858C-DE5E-468E-902E-01FA8CF9C7AF</gtr:id><gtr:title>An ensemble view of thrombin allostery.</gtr:title><gtr:parentPublicationTitle>Biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74d6a3ffbc86542d4a9b4f027be05af4"><gtr:id>74d6a3ffbc86542d4a9b4f027be05af4</gtr:id><gtr:otherNames>Lechtenberg BC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1431-6730</gtr:issn><gtr:outcomeId>pm_12842_22_22944689</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>971E03BA-1C0B-49FE-84BA-E4F95FF5C487</gtr:id><gtr:title>Slow thrombin is zymogen-like.</gtr:title><gtr:parentPublicationTitle>Journal of thrombosis and haemostasis : JTH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7823177e5f34aa3434ec7d9a3574641e"><gtr:id>7823177e5f34aa3434ec7d9a3574641e</gtr:id><gtr:otherNames>Huntington JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1538-7836</gtr:issn><gtr:outcomeId>B1F588AB980</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A50DEA1E-432D-4B22-A7F7-D19E0856BD1B</gtr:id><gtr:title>Molecular basis of thrombin recognition by protein C inhibitor revealed by the 1.6-A structure of the heparin-bridged complex.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ce73e661495882f5061c864c6e2c1985"><gtr:id>ce73e661495882f5061c864c6e2c1985</gtr:id><gtr:otherNames>Li W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>10E466E5E61</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>16BC2534-2C66-4A51-9E82-368C0681DC6B</gtr:id><gtr:title>Serpin structure, function and dysfunction.</gtr:title><gtr:parentPublicationTitle>Journal of thrombosis and haemostasis : JTH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7823177e5f34aa3434ec7d9a3574641e"><gtr:id>7823177e5f34aa3434ec7d9a3574641e</gtr:id><gtr:otherNames>Huntington JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1538-7836</gtr:issn><gtr:outcomeId>GXtVu5Rg9oW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E0D22100-8B53-4F99-86E7-47B97827E37E</gtr:id><gtr:title>Structure of native protein C inhibitor provides insight into its multiple functions.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ce73e661495882f5061c864c6e2c1985"><gtr:id>ce73e661495882f5061c864c6e2c1985</gtr:id><gtr:otherNames>Li W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>FCB9FBCBE7F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>71AAED8F-495A-4FC2-817D-EB78E018D0E4</gtr:id><gtr:title>Serpins in thrombosis, hemostasis and fibrinolysis.</gtr:title><gtr:parentPublicationTitle>Journal of thrombosis and haemostasis : JTH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a57b2388ca356712432d24fcf1ba8ab4"><gtr:id>a57b2388ca356712432d24fcf1ba8ab4</gtr:id><gtr:otherNames>Rau JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1538-7836</gtr:issn><gtr:outcomeId>3774501CC3F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>655EDC83-435A-4B4F-BCB0-B2685E2BA734</gtr:id><gtr:title>Molecular basis of thrombomodulin activation of slow thrombin.</gtr:title><gtr:parentPublicationTitle>Journal of thrombosis and haemostasis : JTH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e9783b6b1bba923ff7b4e32cf046f51a"><gtr:id>e9783b6b1bba923ff7b4e32cf046f51a</gtr:id><gtr:otherNames>Adams TE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1538-7836</gtr:issn><gtr:outcomeId>23B297108AB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F00C55BC-6CB0-4D3A-B755-384F5EC5261B</gtr:id><gtr:title>How Na+ activates thrombin--a review of the functional and structural data.</gtr:title><gtr:parentPublicationTitle>Biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7823177e5f34aa3434ec7d9a3574641e"><gtr:id>7823177e5f34aa3434ec7d9a3574641e</gtr:id><gtr:otherNames>Huntington JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1431-6730</gtr:issn><gtr:outcomeId>59372707A99</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0601596</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>939798CA-B6AE-4C12-9DCC-A0F88F84E6F3</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Blood</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>